A. Mooranian, “In Vitro Assessments of Microencapsulated Viable Cells as a Result of Primary Bile Acid-Encapsulated Formulation for Inflammatory Disorders”, Scr Med, vol. 53, no. 2, pp. 103–115, Jun. 2022, doi: 10.5937/scriptamed53-36574.